Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EURE | ISIN: CA71716W2040 | Ticker-Symbol: G11
Frankfurt
01.11.24
08:10 Uhr
0,004 Euro
-0,002
-30,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PHARMADRUG INC Chart 1 Jahr
5-Tage-Chart
PHARMADRUG INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0010,02513:04

Aktuelle News zur PHARMADRUG Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoPharmadrug Inc (2): Pharmadrug to issue $414,523 in debenture units1
DoPharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units312Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
DoPharmadrug Inc (2): Pharmadrug completes PD-001 stability study2
DoPharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases153Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
20.09.PharmaDrug Subsidiary Begins Prep Work For Clinical Trial Of PD-001 For Viral Infectious Diseases4
19.09.Pharmather Holdings Ltd: Pharmadrug begins start-up work for PD-001 study2
19.09.Pharmadrug Inc (2): Pharmadrug begins start-up work for PD-001 study2
19.09.PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases227Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,...
► Artikel lesen
28.08.Pharmadrug Inc (2): Pharmadrug details plans for cepharanthine development2
28.08.Pharmather Holdings Ltd: Pharmadrug details plans for cepharanthine development3
28.08.PharmaDrug Subsidiary To Focus Development Of PD-001 On Viral Infectious Diseases1
28.08.PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases386Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
21.08.PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening3
21.08.PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins426Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
19.08.Bullish Monday For Marijuana Stocks - Leafbuyer Techs, Pharmadrug Among Top Gainers2
19.08.Pharmather Holdings Ltd: Pharmadrug, Pharmather get OK for PD-001 human trial1
19.08.Pharmadrug Inc (2): Pharmadrug, Pharmather get OK for PD-001 human trial2
19.08.PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial1
19.08.PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine352Toronto, Ontario--(Newsfile Corp. - August 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
23.05.Pharmadrug Inc (2): Pharmadrug's SecureDose signs LOI with licensed dealer4
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3